Suppr超能文献

印度孟买市30年间慢性髓细胞白血病的变化趋势

Changing trends of chronic myeloid leukemia in greater Mumbai, India over a period of 30 years.

作者信息

Dikshit Rajesh P, Nagrani Rajini, Yeole Balkrishna, Koyande Shravani, Banawali Shripad

机构信息

Department of Epidemiology, Tata Memorial Hospital, Mumbai, Maharashtra, India.

出版信息

Indian J Med Paediatr Oncol. 2011 Apr;32(2):96-100. doi: 10.4103/0971-5851.89792.

Abstract

BACKGROUND

Little is known about burden of chronic myeloid leukemia (CML) in India. There is a recent interest to observe incidence and mortality because of advent of new diagnostic and treatment policies for CML.

MATERIALS AND METHODS

We extracted data from the oldest population-based cancer registry of Mumbai for 30 years period from 1976-2005 to observe incidence and mortality rates of CML. We classified the data into four age groups 0-14, 15-29, 30-54 and 55-74 to observe incidence rates in the respective age groups.

RESULTS

The age specific rates were highest for the age group of 55-74 years. No significant change in trends of CML was observed for 30 years period. However, there was a significant reduction in incidence rate for recent 15-years period (Estimated average annual percentage change=-3.9). No significant reduction in mortality rate was observed till 2005.

CONCLUSION

The study demonstrates that age-specific rates for CML are highest in age group of 55-74 years, although they are lower compared to western populations. Significant reduction in incidence of CML in recent periods might be because of reduced misclassification of leukemias. The data of CML has to be observed for another decade to witness reduction in mortality because of changes in treatment management.

摘要

背景

在印度,关于慢性髓性白血病(CML)的负担了解甚少。由于CML新的诊断和治疗政策的出现,最近人们对观察其发病率和死亡率产生了兴趣。

材料与方法

我们从孟买最古老的基于人群的癌症登记处提取了1976年至2005年30年间的数据,以观察CML的发病率和死亡率。我们将数据分为四个年龄组:0 - 14岁、15 - 29岁、30 - 54岁和55 - 74岁,以观察各年龄组的发病率。

结果

55 - 74岁年龄组的年龄别发病率最高。在30年期间,未观察到CML趋势的显著变化。然而,在最近15年期间发病率有显著下降(估计平均年百分比变化 = -3.9)。直到2005年,死亡率没有显著下降。

结论

该研究表明,CML的年龄别发病率在55 - 74岁年龄组最高,尽管与西方人群相比更低。近期CML发病率的显著下降可能是由于白血病误诊率降低。由于治疗管理的变化,CML的数据还需再观察十年才能看到死亡率的下降。

相似文献

1
Changing trends of chronic myeloid leukemia in greater Mumbai, India over a period of 30 years.
Indian J Med Paediatr Oncol. 2011 Apr;32(2):96-100. doi: 10.4103/0971-5851.89792.
2
Lifetime risk and trends in lung cancer incidence in greater Mumbai.
Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):75-82.
4
Mortality and Vascular Events Among Elderly Patients With Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data.
Clin Lymphoma Myeloma Leuk. 2016 May;16(5):275-285.e1. doi: 10.1016/j.clml.2016.01.006. Epub 2016 Feb 6.
5
Italian cancer figures, report 2012: Cancer in children and adolescents.
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
6
Trends in mouth cancer incidence in Mumbai, India (1995-2009): An age-period-cohort analysis.
Cancer Epidemiol. 2016 Jun;42:66-71. doi: 10.1016/j.canep.2016.03.007. Epub 2016 Apr 1.
7
Decreasing trend in mortality of chronic myelogenous leukemia patients after introduction of imatinib in Japan and the U.S.
Oncologist. 2012;17(12):1547-50. doi: 10.1634/theoncologist.2012-0197. Epub 2012 Sep 12.
9
Trends in leukemia incidence and survival in the United States (1973-1998).
Cancer. 2003 May 1;97(9):2229-35. doi: 10.1002/cncr.11316.
10
Cumulative risk and trends in prostate cancer incidence in Mumbai, India.
Asian Pac J Cancer Prev. 2004 Oct-Dec;5(4):401-5.

引用本文的文献

3
Incidence of chronic myeloid leukemia in Calgary, Alberta, Canada.
BMC Res Notes. 2018 Nov 1;11(1):780. doi: 10.1186/s13104-018-3890-8.
4
Variation in Adherence Measures to Imatinib Therapy.
J Glob Oncol. 2018 Sep;4:1-10. doi: 10.1200/JGO.2016.007906. Epub 2017 Mar 24.
5
Chronic Myeloid Leukemia in India.
J Glob Oncol. 2016 Jul 20;3(1):64-71. doi: 10.1200/JGO.2015.002667. eCollection 2017 Feb.
6
Economic evaluation of Mumbai and its satellite cancer registries: Implications for expansion of data collection.
Cancer Epidemiol. 2016 Dec;45 Suppl 1(Suppl 1):S43-S49. doi: 10.1016/j.canep.2016.10.002. Epub 2016 Oct 7.
7
Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer.
Med Oncol. 2016 May;33(5):40. doi: 10.1007/s12032-016-0754-8. Epub 2016 Mar 31.
8
Chronic myeloid leukemia in children and adolescents: A single center experience from Eastern India.
South Asian J Cancer. 2013 Oct;2(4):260-4. doi: 10.4103/2278-330X.119891.

本文引用的文献

1
Epidemiology of chronic myeloid leukaemia (CML).
Best Pract Res Clin Haematol. 2009 Sep;22(3):295-302. doi: 10.1016/j.beha.2009.07.007.
2
Trends in adult leukemia incidence and survival in Denmark, 1943-2003.
Cancer Causes Control. 2009 Nov;20(9):1671-80. doi: 10.1007/s10552-009-9417-9. Epub 2009 Aug 12.
3
Obesity, weight gain, and risk of chronic myeloid leukemia.
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1501-6. doi: 10.1158/1055-9965.EPI-09-0028.
4
Modern approaches to treating chronic myelogenous leukemia.
Curr Oncol Rep. 2008 Sep;10(5):365-71. doi: 10.1007/s11912-008-0057-0.
7
Targeted chronic myeloid leukemia therapy: seeking a cure.
J Manag Care Pharm. 2007 Oct;13(8 Suppl A):8-12. doi: 10.18553/jmcp.2007.13.s8-a.8.
10
Alcohol consumption and risk of leukemia: A multicenter case-control study.
Leuk Res. 2007 Mar;31(3):379-86. doi: 10.1016/j.leukres.2006.07.002. Epub 2006 Aug 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验